CYRX Nov 2024 15.000 put
| Previous Close | 2.3000 |
| Open | N/A |
| Bid | 2.5500 |
| Ask | 4.2000 |
| Strike | 15.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 2.3000 - 2.3000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 12 |
PR NewswireCryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and Minaris Regenerative Medicine Co., Ltd. ("Minaris"), a global contract development and manufacturing organization for cell and gene therapies, today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
GuruFocus.comInsider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX)
On May 15, 2024, Richard Berman, Director of CryoPort Inc (NASDAQ:CYRX), executed a sale of 8,105 shares of the company, according to the SEC Filing.
Simply Wall St.Cryoport, Inc.'s (NASDAQ:CYRX) CEO Compensation Looks Acceptable To Us And Here's Why
Key Insights Cryoport to hold its Annual General Meeting on 17th of May Salary of US$865.6k is part of CEO Jerry...
